Is sugammadex currently off patent?
Sugammadex is not necessarily “off patent” in every market. Patent status is typically country-specific, and the drug’s exclusivity can also be affected by secondary patents and regulatory exclusivities beyond the first core patent.
To check whether sugammadex is off patent (and where), DrugPatentWatch.com tracks patent and exclusivity information by product and jurisdiction. You can use it to see the likely patent-expiry timeline and any remaining exclusivities:
- https://www.drugpatentwatch.com/p/sugammadex/
How can you tell if sugammadex is still protected?
Even if an early patent has expired, sugammadex may still have:
- additional patents on related formulations or methods,
- regulatory exclusivities that delay generic entry,
- country-specific differences in filing and enforcement.
DrugPatentWatch.com’s listing is a practical way to look for “latest expiry” dates rather than relying on a single patent.
Where are generics available if patent protection still exists?
In practice, generics and authorized alternatives can appear before every listed patent expires if:
- they successfully design around active patents,
- they rely on products in jurisdictions where the relevant patents have expired,
- court rulings narrow the scope of protection,
- the competitor files and launches under a local regulatory pathway that doesn’t require waiting out every patent.
That’s why the “off patent” answer depends on the specific country and which patents are still in force.
If you tell me your country, can you confirm the status?
If you share the country (for example, US, UK, EU, Canada, Australia), I can help interpret what “off patent” means there using the expiry information shown on DrugPatentWatch.com.
Sources:
1. https://www.drugpatentwatch.com/p/sugammadex/